Live feed06:30:00·649dPRReleasevia QuantisnowAura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal MelanomaByQuantisnow·Wall Street's wire, on your screen.AURA· Aura Biosciences Inc.Health Care
